An Evidence-Based Approach to COPD: Part 1

被引:6
作者
Corbridge, Susan [1 ,2 ,3 ]
Wilken, Lori [4 ,5 ]
Kapella, Mary C.
Gronkiewicz, Cindy
机构
[1] Univ Illinois, Chicago Coll Nursing, Acute Care Nurse Practitioner Program, Chicago, IL 60680 USA
[2] Univ Illinois, Chicago Coll Nursing, Clin Nurse Specialist Program, Chicago, IL 60680 USA
[3] Univ Illinois, Chicago Med Ctr, Dept Pulm & Crit Care Med, Chicago, IL 60680 USA
[4] Univ Illinois, Chicago Coll Pharm, Chicago, IL 60680 USA
[5] Univ Illinois, Chicago Med Ctr, Dept Pulm Med, Chicago, IL 60680 USA
关键词
chronic bronchitis; chronic obstructive pulmonary disease; emphysema; patient education; respiratory disease; OBSTRUCTIVE PULMONARY-DISEASE; AMERICAN THORACIC SOCIETY; SALMETEROL/FLUTICASONE PROPIONATE; SYSTEMIC MANIFESTATIONS; CARDIOVASCULAR EVENTS; TIOTROPIUM; RISK; EXACERBATIONS; INDACATEROL; SALMETEROL;
D O I
10.1097/01.NAJ.0000412639.08764.21
中图分类号
R47 [护理学];
学科分类号
101102 [成人与老年护理学];
摘要
OVERVIEW: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States, affecting as many as 24 million Americans and resulting in 1.5 million ED visits, 700,000 hospital admissions, and 124,000 deaths annually. This article, the first in a two-part series on COPD, outlines current guidelines and other evidence-based recommendations on diagnosing and managing stable COPD in the outpatient setting. Part 2 will appear in a future issue of AJN and will focus on man aging acute exacerbations of COPD.
引用
收藏
页码:46 / 57
页数:12
相关论文
共 59 条
[1]
Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease [J].
Aaron, SD ;
Vandemheen, KL ;
Hebert, P ;
Dales, R ;
Stiell, IG ;
Ahuja, J ;
Dickinson, G ;
Brison, R ;
Rowe, BH ;
Dreyer, J ;
Yetisir, E ;
Cass, D ;
Wells, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2618-2625
[3]
[Anonymous], 1980, Ann Intern Med, V93, P391
[4]
[Anonymous], STAND DIAGN MAN PAT
[5]
[Anonymous], NATL VITAL STAT REPO
[6]
[Anonymous], GLOB STRAT DIAGN MAN
[7]
Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease [J].
Baghai-Ravary, Ramin ;
Quint, Jennifer K. ;
Goldring, James J. P. ;
Hurst, John R. ;
Donaldson, Gavin C. ;
Wedzicha, Jadwiga A. .
RESPIRATORY MEDICINE, 2009, 103 (02) :216-223
[8]
Fatigue in COPD: Prevalence and effect on outcomes in pulmonary rehabilitation [J].
Baltzan, Marcel A. ;
Scott, Adrienne S. ;
Wolkove, Norman ;
Bailes, Sally ;
Bernard, Sarah ;
Bourbeau, Jean ;
Maltais, Francois .
CHRONIC RESPIRATORY DISEASE, 2011, 8 (02) :119-128
[9]
Systemic manifestations and comorbidities of COPD [J].
Barnes, P. J. ;
Celli, B. R. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (05) :1165-1185
[10]
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789